ArticleTobacco control2026
Measured and modelled nicotine emissions predict systemic nicotine exposure across sub-ohm and pod-based ENDS.
Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundElectronic nicotine delivery systems (ENDS) can deliver nicotine at levels that rival or exceed cigarettes, shaping both smoking cessation outcomes and the emergence of nicotine dependence in previously nicotine-naïve users. We evaluated whether systemic nicotine exposure is associated with emitted nicotine dose measured in the laboratory and estimated from ENDS device physics.
methodsAcross two clinical studies, we compared plasma nicotine boost following ad libitum ENDS puffing sessions with nicotine doses derived by two complementary approaches: (1) analysis of nicotine content in puffing-machine-generated aerosols and (2) physics-based computer simulations.
resultsAcross both clinical datasets and three device types, plasma nicotine boost was associated with emitted nicotine dose measured in the laboratory (~40% of variance explained) and with that predicted by a first-principles model of coil heating and liquid vaporisation (~33%), despite not incorporating individual-participant physiological differences.
conclusionsThese results support a mechanistic link between ENDS device parameters and systemic nicotine exposure. Physics-based models may support prospective population-level evaluation of nicotine delivery, including for hypothetical products, for which emissions data are not yet available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.